Bio Pharma Dive
FEBRUARY 15, 2022
Early study results suggest some efficacy for Amgen's KRAS-targeting drug in the tough-to-treat cancer type. The biotech plans to expand testing as a result.
World of DTC Marketing
FEBRUARY 15, 2022
Biotech startups are hurting for money as investments in biotech startups start to decline. Biotechs need to think like marketers to cut through the noise and attract investors. It begins with a CEO who not only has a stellar medical background but understands how to get the company on the radar. There are so many biotech startups right now that there isn’t enough money for them all to continue the development of new drugs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 15, 2022
By partnering with ONK Therapeutics, Intellia joins CRISPR Therapeutics and Editas Medicine in striking deals that marry gene editing with a fast-emerging form of cancer immunotherapy.
Pharma Times
FEBRUARY 15, 2022
Francis Crick Institute and King’s College London collaborate to identify specialist cells which protect DNA
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
FEBRUARY 15, 2022
One in four of the world’s rivers are polluted with potentially toxic levels of pharma compounds, according to a new study. The findings point to a “threat to environmental and global health,” say the scientists, who found that paracetamol, antibiotics epilepsy drug carbamazepine, metformin for diabetes and other compounds like caffeine and nicotine were found in samples from around the world – including in Antarctica.
Intouch Solutions
FEBRUARY 15, 2022
Each year, we ask Intouch creatives to share their thoughts on the latest Super Bowl ads. This year, for Super Bowl LVI, we’re back with more creatives and more reactions. But wait: When you get a bunch of creatives (and one strategic planner) “in a room together,” can you get quick consensus? Turns out yes. Pretty much everyone agreed that the audience in mind was Gen X; that celebrities were more rampant than ever; and Eugene Levy driving fast with Fabio hair is AWESOME.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
FEBRUARY 15, 2022
GEN Biotechnology announces the publication of its inaugural issue. The Journal publishes outstanding peer-reviewed research and perspectives in all aspects of biotechnology. The Journal, led by Editor-in-Chief Hana El-Samad, PhD (University of California San Francisco; Altos Labs) and Executive Editor Kevin Davies, PhD is published bimonthly in print and online.
Outsourcing Pharma
FEBRUARY 15, 2022
The institute and the research/support organization will collaborate on development of novel therapies aimed at treating the central nervous system disorder.
Scienmag
FEBRUARY 15, 2022
EL PASO, Texas (Feb. 15, 2022) — Student researchers at The University of Texas at El Paso Aerospace Center will engage in nuclear materials technology research through a five-year, $5 million grant from the U.S. Department of Energy (DOE). The award renews the Partnership for Research and Education Consortium in Ceramics and Polymers (PRE-CCAP). Credit: […].
Pharma Times
FEBRUARY 15, 2022
Oxford university spin out company develops tech to identify viruses in seconds
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
FEBRUARY 15, 2022
Research by Japanese scientists at Hiroshima University reveals a way to make ammonia from its constituent molecules of nitrogen and hydrogen at ambient pressure. Credit: Hiroki Miyaoka, Hiroshima University Research by Japanese scientists at Hiroshima University reveals a way to make ammonia from its constituent molecules of nitrogen and hydrogen at ambient pressure.
Drug Channels
FEBRUARY 15, 2022
Time to update Drug Channels' exclusive look at independent pharmacy owners’ business economics. Our analysis again reveals that despite what you may have heard, many independent pharmacies continue to hang on in a highly challenging retail environment. Prescription profits remained stable, while the average pharmacy owner’s salary jumped for the second year.
Scienmag
FEBRUARY 15, 2022
Researchers at the University of Nottingham have devised a revolutionary new technique for measuring the microscopic elasticity of materials for the first time. Known as SRAS, the technology works by measuring the speed of sound across the material’s surface. Credit: University of Nottingham Researchers at the University of Nottingham have devised a revolutionary new technique […].
pharmaphorum
FEBRUARY 15, 2022
Digital health and technologies offer a wealth of opportunities, but digital needs to become part of a company’s DNA to achieve transformation. Rodamni Peppa, Boston Scientific’s vice-president for business strategy & commercial excellence for Europe, the Middle East and Africa, gives insight into a four-year digital journey with Dr Paul Tunnah at the 2021 Frontiers Health conference in Milan.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
FEBRUARY 15, 2022
Parents face a trade-off between putting resources into their offspring versus using resources to enhance their chances of survival so they can have more offspring. The best allocation of resources depends on age. More experienced parents are better at getting food, so they can pass on more to their offspring. However, resources are needed to […].
BioPharma Reporter
FEBRUARY 15, 2022
OxDX has raised Â2.6m (US$3.5m) in pre-seed funding to develop AI powered rapid diagnostic technology.
Scienmag
FEBRUARY 15, 2022
As many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause muscle pain and other side-effects. Now, a new study of over four million patients has shown that the true prevalence of statin intolerance worldwide is between six to ten percent. Credit: […].
Drug Patent Watch
FEBRUARY 15, 2022
Annual Drug Patent Expirations for CABENUVA+KIT Cabenuva Kit is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are five…. The post New patent for Viiv Hlthcare drug CABENUVA KIT appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
FEBRUARY 15, 2022
HOUSTON – (Feb. 15, 2022) – Phonons are collective atomic vibrations, or quasiparticles, that act as the main heat carriers in a crystal lattice. Under certain circumstances, their properties can be modified by electric fields or light. But until now, nobody noticed they can respond to magnetic fields as well. Credit: Jeff Fitlow/Rice University HOUSTON – (Feb. 15, 2022) […].
Drug Patent Watch
FEBRUARY 15, 2022
Annual Drug Patent Expirations for PROMACTA+KIT Promacta Kit is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents…. The post New patent for Novartis drug PROMACTA KIT appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
FEBRUARY 15, 2022
The Atlas cedar, or Cedrus atlantica (Endl. Manetti ex Carrière)is a species that belongs to Mediterranean mountain conifers, and is found in North Africa (Morocco and Algeria). Although this is geographically close to the Iberian Peninsula, it can still be considered an exotic species in Spain, as paleobotanical records do not confirm its natural presence. […].
Imperical Blog
FEBRUARY 15, 2022
The number of global trials grows every year, with study teams reaching out to increasingly diverse patient populations. These broader populations bring a growing variety of languages, cultures and experiences – all… The post Machine Translation: OK for Your Clinical Trial Materials? appeared first on Imperial Clinical Research Services Blog; Trending Topics.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
FEBRUARY 15, 2022
During the first weeks of the COVID-19 vaccine rollout in December 2020, Kathryn Freeman Anderson searched far and wide for places to get her parents, who are older than 65, vaccinated. The extensive search prompted the University of Houston associate professor of sociology to look at the map of Houston sites, and knowing the demographics […].
BioPharma Reporter
FEBRUARY 15, 2022
IASO Biotherapeutics and Innovent Biologics have announced that the FDA has granted Orphan Drug Designation (ODD) to their fully human anti-B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed and/or refractory multiple myeloma (R/R MM).
Scienmag
FEBRUARY 15, 2022
microRNAs (miRNA), non-coding RNA molecules, are widely known for regulating mRNA stability and translation. miR-10b has been increasingly implicated in the pathogenesis of gliomas, cancers of the brain. Given the therapeutic potential of targeting miR-10b, researchers at the Brigham sought to understand the mechanism behind the glioma dependence, often referred to as addiction, on miR-10b. […].
BioPharma Reporter
FEBRUARY 15, 2022
AffaMed Therapeutics has announced that the US FDA has cleared its Investigational New Drug (IND) application for the clinical development of AM712 (ASKG712), a novel proprietary bispecific biologic molecule blocking both vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2) for the treatment of retinal vascular diseases.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
FEBRUARY 15, 2022
[New York, February 15, 2022] – Amit Bar-Or, MD, of the University of Pennsylvania, is this year’s recipient of the Barancik Prize for Innovation in MS Research for work uncovering how the immune system drives multiple sclerosis and cutting-edge research focusing on precision medicine to achieve long-term remission and ultimately preventing progression of the disease. […].
pharmaphorum
FEBRUARY 15, 2022
Armed with new clinical trial results, Amgen is expanding studies of its KRAS inhibitor Lumakras in pancreatic cancer, as it tries to extend the label for the first-in-class drug beyond its current use in non-small cell lung cancer (NSCLC). Data from the CodeBreaK 100 phase 1/2 trial showed “encouraging and clinically meaningful anticancer activity” for Lumakras (sotorasib) in patients with KRAS G12C-mutated advanced pancreatic cancer , including an objective response rate (ORR) of 2
Scienmag
FEBRUARY 15, 2022
Researchers at Uppsala University have discovered that the ancestors of legionella bacteria infected eukaryotic cells as early as two billion years ago. It happened soon after eukaryotes began to feed on bacteria. These results, described in a new study published in Molecular Biology and Evolution, also contributes to the chicken-or-egg debate about whether mitochondria or […].
pharmaphorum
FEBRUARY 15, 2022
ImmunoGenAlmost four years after backing out of an antibody-drug conjugate (ADC) alliance with ImmunoGen, Eli Lilly has come back to the table with a new, wide-ranging deal worth up to $1.7 billion. Like the earlier agreement, the new deal is focused on one of ImmunoGen’s payload technologies, the toxic molecules that add a cell-killing punch when linked to antibodies that are used to target antigens on cancer cells.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
300 
Let's personalize your content